TY - JOUR
T1 - Benzodiazepine-Free Cardiac Anesthesia for Reduction of Postoperative Delirium
T2 - A Cluster Randomized Crossover Trial
AU - Spence, Jessica
AU - Devereaux, P. J.
AU - Lee, Shun Fu
AU - D'Aragon, Frédérick
AU - Avidan, Michael S.
AU - Whitlock, Richard P.
AU - Mazer, C. David
AU - Rousseau-Saine, Nicolas
AU - Rajamohan, Raja Ramaswamy
AU - Pryor, Kane O.
AU - Klein, Rael
AU - Tan, Edmund
AU - Cameron, Matthew J.
AU - Di Sante, Emily
AU - Deborba, Erin
AU - Mustard, Mary E.
AU - Couture, Etienne J.
AU - Zamper, Raffael Pereira Cezar
AU - Law, Michael W.Y.
AU - Djaiani, George
AU - Saha, Tarit
AU - Choi, Stephen
AU - Hedlin, Peter
AU - Pikaluk, D. Ryan
AU - Lam, Wing
AU - Deschamps, Alain
AU - Ramasundarahettige, Chinthanie F.
AU - Vincent, Jessica
AU - McIntyre, William F.
AU - Oczkowski, Simon J.W.
AU - Dulong, Braden J.
AU - Beaver, Christopher
AU - Kloppenburg, Shelley A.
AU - Lamy, Andre
AU - Jacobsohn, Eric
AU - Belley-Côté, Emilie P.
N1 - Publisher Copyright:
© 2025 American Medical Association. All rights reserved, including those for text and data mining, AI training, and similar technologies.
PY - 2025/3/12
Y1 - 2025/3/12
N2 - Importance: Delirium is common after cardiac surgery and associated with adverse outcomes. Intraoperative benzodiazepines may increase postoperative delirium but restricting intraoperative benzodiazepines has not yet been evaluated in a randomized trial. Objective: To determine whether an institutional policy of restricted intraoperative benzodiazepine administration reduced the incidence of postoperative delirium. Design, Setting, and Participants: This pragmatic, multiperiod, patient- and assessor-blinded, cluster randomized crossover trial took place at 20 North American cardiac surgical centers. All adults undergoing open cardiac surgery at participating centers during the trial period were included through a waiver of individual patient consent between November 2019 and December 2022. Intervention: Institutional policies of restrictive vs liberal intraoperative benzodiazepine administration were compared. Hospitals (clusters) were randomized to cross between the restricted and liberal benzodiazepine policies 12 to 18 times over 4-week periods. Main Outcomes and Measures: The primary outcome was the incidence of delirium within 72 hours of surgery as detected in routine clinical care, using either the Confusion Assessment Method-Intensive Care Unit or the Intensive Care Delirium Screening Checklist. Intraoperative awareness by patient report was assessed as an adverse event. Results: During the trial, 19768 patients (mean [SD] age, 65 [12] years; 14528 [73.5%] male) underwent cardiac surgery, 9827 during restricted benzodiazepine periods and 9941 during liberal benzodiazepine periods. During restricted periods, clinicians adhered to assigned policy in 8928 patients (90.9%), compared to 9268 patients (93.2%) during liberal periods. Delirium occurred in 1373 patients (14.0%) during restricted periods and 1485 (14.9%) during liberal periods (adjusted odds ratio [aOR], 0.92; 95% CI, 0.84-1.01; P =.07). No patient spontaneously reported intraoperative awareness. Conclusions and Relevance: In intention-to-treat analyses, restricting benzodiazepines during cardiac surgery did not reduce delirium incidence but was also not associated with an increase in the incidence of patient-reported intraoperative awareness. Given that smaller effect sizes cannot be ruled out, restriction of benzodiazepines during cardiac surgery may be considered. Research is required to determine whether restricting intraoperative benzodiazepines at the patient level can reduce the incidence of postoperative delirium. Trial Registration: ClinicalTrials.gov Identifier: NCT03928236.
AB - Importance: Delirium is common after cardiac surgery and associated with adverse outcomes. Intraoperative benzodiazepines may increase postoperative delirium but restricting intraoperative benzodiazepines has not yet been evaluated in a randomized trial. Objective: To determine whether an institutional policy of restricted intraoperative benzodiazepine administration reduced the incidence of postoperative delirium. Design, Setting, and Participants: This pragmatic, multiperiod, patient- and assessor-blinded, cluster randomized crossover trial took place at 20 North American cardiac surgical centers. All adults undergoing open cardiac surgery at participating centers during the trial period were included through a waiver of individual patient consent between November 2019 and December 2022. Intervention: Institutional policies of restrictive vs liberal intraoperative benzodiazepine administration were compared. Hospitals (clusters) were randomized to cross between the restricted and liberal benzodiazepine policies 12 to 18 times over 4-week periods. Main Outcomes and Measures: The primary outcome was the incidence of delirium within 72 hours of surgery as detected in routine clinical care, using either the Confusion Assessment Method-Intensive Care Unit or the Intensive Care Delirium Screening Checklist. Intraoperative awareness by patient report was assessed as an adverse event. Results: During the trial, 19768 patients (mean [SD] age, 65 [12] years; 14528 [73.5%] male) underwent cardiac surgery, 9827 during restricted benzodiazepine periods and 9941 during liberal benzodiazepine periods. During restricted periods, clinicians adhered to assigned policy in 8928 patients (90.9%), compared to 9268 patients (93.2%) during liberal periods. Delirium occurred in 1373 patients (14.0%) during restricted periods and 1485 (14.9%) during liberal periods (adjusted odds ratio [aOR], 0.92; 95% CI, 0.84-1.01; P =.07). No patient spontaneously reported intraoperative awareness. Conclusions and Relevance: In intention-to-treat analyses, restricting benzodiazepines during cardiac surgery did not reduce delirium incidence but was also not associated with an increase in the incidence of patient-reported intraoperative awareness. Given that smaller effect sizes cannot be ruled out, restriction of benzodiazepines during cardiac surgery may be considered. Research is required to determine whether restricting intraoperative benzodiazepines at the patient level can reduce the incidence of postoperative delirium. Trial Registration: ClinicalTrials.gov Identifier: NCT03928236.
UR - http://www.scopus.com/inward/record.url?scp=85218176231&partnerID=8YFLogxK
U2 - 10.1001/jamasurg.2024.6602
DO - 10.1001/jamasurg.2024.6602
M3 - Article
C2 - 39878960
AN - SCOPUS:85218176231
SN - 2168-6254
VL - 160
SP - 286
EP - 294
JO - JAMA surgery
JF - JAMA surgery
IS - 3
ER -